0.00Open0.80Pre Close0 Volume52 Open Interest25.00Strike Price0.00Turnover174.73%IV42.38%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier16DDays to Expiry0.80Extrinsic Value100Contract SizeAmericanOptions Type0.2426Delta0.0473Gamma22.65Leverage Ratio-0.0652Theta0.0016Rho5.49Eff Leverage0.0118Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet